triazolam has been researched along with Acquired Immunodeficiency Syndrome in 2 studies
Triazolam: A short-acting benzodiazepine used in the treatment of insomnia. Some countries temporarily withdrew triazolam from the market because of concerns about adverse reactions, mostly psychological, associated with higher dose ranges. Its use at lower doses with appropriate care and labeling has been reaffirmed by the FDA and most other countries.
Acquired Immunodeficiency Syndrome: An acquired defect of cellular immunity associated with infection by the human immunodeficiency virus (HIV), a CD4-positive T-lymphocyte count under 200 cells/microliter or less than 14% of total lymphocytes, and increased susceptibility to opportunistic infections and malignant neoplasms. Clinical manifestations also include emaciation (wasting) and dementia. These elements reflect criteria for AIDS as defined by the CDC in 1993.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Greenblatt, DJ | 1 |
| von Moltke, LL | 1 |
| Daily, JP | 1 |
| Harmatz, JS | 1 |
| Shader, RI | 1 |
| Smirne, S | 1 |
| Ferini-Strambi, L | 1 |
1 review available for triazolam and Acquired Immunodeficiency Syndrome
| Article | Year |
|---|---|
Extensive impairment of triazolam and alprazolam clearance by short-term low-dose ritonavir: the clinical dilemma of concurrent inhibition and induction.
Topics: Acquired Immunodeficiency Syndrome; Alprazolam; Animals; Aryl Hydrocarbon Hydroxylases; Cytochrome P | 1999 |
1 trial available for triazolam and Acquired Immunodeficiency Syndrome
| Article | Year |
|---|---|
Clinical applications of cyclic alternating pattern.
Topics: Acquired Immunodeficiency Syndrome; Adult; Anticonvulsants; Electroencephalography; GABA Modulators; | 1999 |